SOD2-Superoxide Metabolic Axis Regulates Mitophagy and Modulates TKIs Sensitivity in Head and Neck Squamous Cell
Wan-Hang Zhou1, Shuo-Jin Huang1, An-Xun Wang1
1Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Abstract:
Superoxide dismutase 2 (SOD2) has been implicated in head and neck squamous cell carcinoma (HNSCC), yet its mechanistic contribution in regulating tumor responses to tyrosine kinase inhibitors (TKIs) remains unclear. Here, we investigated whether SOD2 shapes TKI sensitivity in HNSCC through a mitochondrial superoxide-mitophagy axis. Bioinformatic analyses revealed that elevated SOD2 expression was negatively correlated with mitophagy signatures in HNSCC. Functional experiments showed that SOD2 silencing led to mitochondrial superoxide accumulation, impaired mitochondrial function, and significant mitophagy activation in HNSCC cells. Pharmacological modulation further supported a superoxide-dependent mechanism, as Mito-TEMPO suppressed mitochondrial superoxide and mitophagy induction, whereas rotenone enhanced mitochondrial superoxide and mitophagy activity. Importantly, SOD2 knockdown increased apoptotic susceptibility and sensitized HNSCC cells to TKI treatment, which was partially reversed by superoxide scavenging but reinforced by superoxide elevation. Consistently, SOD2 knockout xenograft models exhibited enhanced antitumor responsiveness to TKIs in vivo. Collectively, these findings identified SOD2 as a key regulator of mitochondrial redox homeostasis and mitophagy, thereby modulating therapeutic sensitivity in HNSCC, and suggest that targeting the SOD2-superoxide metabolic axis may represent a promising strategy to improve TKIs efficacy in HNSCC.
Insights
Superoxide dismutase 2 (SOD2) impacts head and neck cancer (HNSCC) drug response. Targeting SOD2 and its related superoxide metabolism may enhance tyrosine kinase inhibitor (TKI) effectiveness in HNSCC treatment.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Superoxide dismutase 2 (SOD2) is linked to head and neck squamous cell carcinoma (HNSCC).
- The precise role of SOD2 in regulating tumor response to tyrosine kinase inhibitors (TKIs) in HNSCC is not fully understood.
- Investigating the mitochondrial superoxide-mitophagy pathway offers a potential mechanism.
Purpose of the Study:
- To determine if SOD2 influences TKI sensitivity in HNSCC via a mitochondrial superoxide-mitophagy axis.
- To elucidate the mechanistic link between SOD2, mitochondrial function, and mitophagy in HNSCC cells.
- To evaluate the therapeutic potential of targeting the SOD2-superoxide axis for improving TKI efficacy.
Main Methods:
- Bioinformatic analysis of SOD2 expression and mitophagy signatures in HNSCC.
- In vitro functional experiments involving SOD2 silencing and pharmacological modulators (Mito-TEMPO, rotenone).
- In vivo studies using SOD2 knockout xenograft models treated with TKIs.
Main Results:
- Elevated SOD2 expression negatively correlated with mitophagy signatures in HNSCC.
- SOD2 silencing caused mitochondrial superoxide accumulation, impaired function, and activated mitophagy.
- SOD2 knockdown sensitized HNSCC cells to TKIs, an effect modulated by superoxide levels.
- SOD2 knockout xenografts showed improved antitumor response to TKIs.
Conclusions:
- SOD2 is a critical regulator of mitochondrial redox homeostasis and mitophagy in HNSCC.
- The SOD2-superoxide metabolic axis significantly modulates HNSCC sensitivity to TKIs.
- Targeting SOD2 and superoxide metabolism presents a promising strategy to enhance TKI efficacy in HNSCC.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...


